Oral semaglutide is administered as a once-daily pill, generally taken on an empty stomach
It's the most flexible oral GLP-1 weight loss medication available, with clinical trials showing an average weight loss of 12.4%
The APRN assessment at this stage determines whether additional support is indicated
Its not yet approved, so the conversation with a doctor right now is about whats in the pipeline, whether current GLP-1 options are working, and whether to watch for survodutide trials to participate in, she said
Participants in both the Tirzepatide and Semaglutide treatment arms received lifestyle intervention, including a reduced-calorie diet and increased physical activity
In fact, it's the reason "miracle" drugs like Ozempic and Wegovy have skyrocketed in popularity